





THE intensity of competition to gain entrance to a medical school
has often been commented on and concern has been felt at unethical
conduct before entrance-cheating, stealing notes, and sabotaging
other students’ experiments. Having been accepted, there is, in
most cases, the hurdle of the examinations of the National Board of
Medical Examiners. At this level, the students of the medical
schools in the US are joined by those from overseas or offshore
medical schools, and immigrants hoping to practise, lucratively, in
the States. Only with these hurdles passed, including the Flex
examination for foreign medical graduates, can graduates hope to
reap the golden harvest unless they present false credentials. The
extent of fraud is now so widespread that the credentials of hundreds
of physicians are being closely scrutinised. Recently it has become
clear that fraud and cheating in examinations is common at every
level, since papers have been stolen, copied, and sold, sometimes at
high prices. Examination after examination has been compromised
in this way. The medical college aptitude test, widely used as an
entry criterion, was found last year to have been available to many
examinees before they sat the paper while, at the same time, the
examination for doctors trained overseas was so badly compromised
that a quarter of those sitting it had prior knowledge of the
questions. Person or persons unknown stole a copy, sold it for
$50 000, the purchaser made copies available at$10 000 to others,
who made further copies and sold them at$5 000 apiece. Such
practices have increased in the past few years. Some individuals
have been caught trying to bribe people to obtain copies of the
examinations but the investigations made so far have not identified
the original thieves, though inquiries are being actively pursued in
several states, one country overseas, and one area of the Caribbean.
When illegally-acquired copies of examinations may be bought in
the streets, something drastic must be done. These practices
question the whole examination system and the easily memorised
multiple-choice questions in particular. Dr Cooper, of the
Association of American Medical Colleges, believes that different
tests might be used, including essay-type questions. Here he points,
perhaps, to the key issue. How far should medical schools take
responsibility for insuring that their graduates are of acceptable
calibre? For years, many have taken the attitude that a student who
is good enough to be accepted is automatically entitled to graduate.
Few if any colleges have final examinations, clinical examinations,
or even monitor standards by using external examiners, and many
appear indifferent to the standards achieved. If students can pass the
National Boards, well and good, but if they cannot, they may still be
awarded an MD. It seems likely that without a change in attitudes
within medical colleges the situation will persist or get worse.
In the past the medical profession has enjoyed high public esteem
and enjoyed a rich financial status. But if there are not a few
physicians with frankly fraudulent credentials and a high
proportion suspected of cheating their way to licensure, then public
opinion may be less favourable.
West Germany
BITTER PILLS&mdash;A WASTED OPPORTUNITY?
SINCE January a book called Bittere Pillenl (bitter pills) has headed
the best-seller list in West Germany, having drawn an enthusiastic
welcome from commentators in magazines and on television, and
apparently also a substantial section of society. The German
Medical Association, the pharmaceutical industry, and the
professional journals take a very different view, and have attacked it
fiercely. Such a medical "war" has not been seen since 1976 when
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Hackenthal launched his book on malpractice in surgery. 2
The book-offered in gorgeous blue covers-provides
information on more than 2000 drugs that account for about 80% of
West Germany and Austria’s pharmaceutical market. Along with
short accounts of clinical symptoms, body systems, and diseases, it
provides a somewhat unsystematic description of the unwanted and
wanted effects of drugs in each of 75 areas of application. The
emphasis is very much on the unwanted effects, and the information
is qualitative rather than quantitative. The few references are
almost exclusively to secondary publications-notably, a single
textbook of pharmacology3 and the "transparenz-telegram" (a
critical guide for doctors and consumers published by a private drug
information agency in West Berlin). In clearly’laid out tables the
book offers simple value judgments on each drug including
classification under the headings "general useful", "useful only in
limited conditions", "barely useful", and "not useful but
dangerous" (in which case the reader is advised not to take it).
Additional tables carry information (some of it never intended for
the public eye) on the economics of each drug including worth of
business and number of packages sold in 1981, on the costs of a
single package in the chemist’s shop, on different formulations, and
on whether it is prescription-only or over-the-counter. The
Austrian authors-two journalists, a sociologist, and a chemist who
was formerly sales manager in a West German pharmaceutical
company-have written a previous best-seller, Gesunde Geschdfte,4 4
which revealed shady practices in the pharmaceutical industry and
published confidential letters between companies and doctors
(mainly academics).
What should we make of this enterprise? For the doctors being
pilloried it is difficult to take a detached view, but the information
does seem deficient in many ways. Disease presentation and severity
are not discussed; incidence and extent of drug effects (whether
beneficial or adverse) are not specified; and statements tend to be
based not on clinical trials but on (sometimes obsolete) reports of
experimental pharmacology-a direct and dangerous consequence
of West Germany’s attitude to controlled studies.S Economic data
are accurate, but the reader is in no position to weigh costs against
benefits when the other information is so impressionistic. For
example, all antihistamines are dismissed as weakly and unreliably
effective, therefore seldom useful; so the advice is not to take them in
any kind of allergic reaction. This judgment is based on faulty
citation of the pharmacological textbook neglect of the verdict of
the transparenz-telegram, and complete failure to notice recently
published trials on allergic rhinitisb and anaphylactoid reactions.&deg;8
Why is this book a best-seller? Not only patients but also doctors
are deluged with misleading news about the benefits and risks of
drugs, and there is undoubtedly a need for terse, simple
information. The firm pronouncements of Bittere Pillen may be
wrong-sometimes even dangerously so-but they fill this need.
Lastly, the man-in-the-street regards drugs with considerable
emotion, and the text is well geared to this. It addresses anxieties
about multinational companies, attacks their profits, and blames the
industry for causing excessive drug consumption (and the doctors
for complicity). But why was this book not written by any of us in
the medical profession?
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